Bonraybio CoTPE:6955 65 Gross Margin % is 76.95% as of Dec. 2025, which is 0% above its 10-year median of 76.85. GuruFocus rates TPE:6955 with a GF Score™ of 65/100 and a GF Value™ of NT$184.74 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Bonraybio Co ranks better than 89.69% on this metric.
The historical rank and industry rank for Bonraybio Co's Gross Margin % or its related term are showing as below:
TPE:6955'
s Gross Margin % Range Over the Past 10 Years
Min: 70.3 Med: 76.85 Max: 81.04
Current: 77.87
During the past 6 years, the highestGross Margin % of Bonraybio Co was 81.04%. The lowest was 70.30%. And the median was 76.85%.
TPE:6955's Gross Margin % is ranked better than 89.69% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs TPE:6955: 77.87
Bonraybio Co had a gross margin of 76.95% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Bonraybio Co was 0.40% per year.
Bonraybio Co (TPE:6955) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bonraybio Co had a gross margin of 76.95% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bonraybio Co Gross Margin % Related Terms
Bonraybio Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bonraybio Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6955 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Bonraybio Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonraybio Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonraybio Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bonraybio Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bonraybio Co (TPE:6955) has a Gross Margin % of 76.95% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Bonraybio Co and its competitors. This is near median its historical median of 76.85. Over the past decade, Bonraybio Co's Gross Margin % has ranged from 70.30 to 81.04. According to the industry distribution chart, Bonraybio Co ranks #83 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 10.3%.
Is Bonraybio Co's Gross Margin % too high?
Bonraybio Co's current Gross Margin % of 76.95% is near median its 10-year median of 76.85. Over the past 10 years, this metric has ranged from a low of 70.30 to a high of 81.04. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Bonraybio Co's value of 76.95% is 47.9% above this industry median. Based on the distribution chart, Bonraybio Co ranks #83 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bonraybio Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonraybio Co's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bonraybio Co ranks #83 out of 805 companies for Gross Margin %. This places Bonraybio Co in the top 10% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.03. Bonraybio Co's value of 76.95% is 47.9% above this benchmark. Historically, Bonraybio Co's own Gross Margin % has ranged from 70.30 to 81.04 over the past decade. While the company's 10-year median is 76.85 vs. the industry median of 52.03, Bonraybio Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonraybio Co's current Gross Margin % of 76.95% is 47.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bonraybio Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonraybio Co's current Gross Margin % is 76.95%, which is near median its own 10-year median of 76.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonraybio Co stock overvalued right now?
Based on GuruFocus' analysis, Bonraybio Co (TPE:6955) is currently considered Possible Value Trap. The stock's GF Value™ is NT$184.74, compared to a current price of NT$120.50 — trading 34.8% below its estimated fair value. The current Gross Margin % is 76.95%, which is near median its 10-year median of 76.85 and 47.9% above the Medical Devices & Instruments industry median of 52.03. Bonraybio Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bonraybio Co (TPE:6955), the current Gross Margin % is 76.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonraybio Co (TPE:6955) Overvalued in 2026?
Based on GuruFocus' analysis, Bonraybio Co stock appears to be undervalued.
The current stock price of NT$120.50 is trading 34.8% below its estimated GF Value™ of NT$184.74.
GuruFocus considers Bonraybio Co to be Possible Value Trap.
Key valuation signals for TPE:6955:
Gross Margin %: 76.95% (near median its 10-year median of 76.85)
GF Value™: NT$184.74 vs. price of NT$120.50 (34.8% below fair value)
Industry Position: 47.9% above the Medical Devices & Instruments median (#83 of 805)
No single metric tells the full story. See the TPE:6955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonraybio Co Ltd engages in research, development, and manufacturing of vitro diagnostic devices. The firm produces semen quality analyzers and Semen Analysis Systems for the clinic.
65GF Score
Get the complete analysis for TPE:6955
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6955 has been successfully added to your 
